Cromolyn Sodium: Basic Mechanisms and Clinical Usage
- 1 January 1988
- journal article
- Published by Mary Ann Liebert Inc in Pediatric Asthma, Allergy & Immunology
- Vol. 2 (4) , 237-254
- https://doi.org/10.1089/pai.1988.2.237
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Disodium cromoglycate inhibits activation of human inflammatory cells in vitroJournal of Allergy and Clinical Immunology, 1987
- Cromolyn inhibition of protein kinase C activityBiochemical Pharmacology, 1987
- Inhibition of IgE‐dependent histamine release from human dispersed lung mast cells by anti‐allergic drugs and salbutamolBritish Journal of Pharmacology, 1987
- Anti-asthma drugs attenuate inflammatory leakage of plasma into airway lumenActa Physiologica Scandinavica, 1986
- Human mast cells recovered by bronchoalveolar lavage: their morphology, histamine release and the effects of sodium cromoglycateClinical Science, 1985
- Bronchoalveolar lavage in asthma: The effect of disodium cromoglycate (cromolyn) on leukocyte counts, immunoglobulins, and complementJournal of Allergy and Clinical Immunology, 1984
- A binding site on mast cells and basophils for the anti-allergic drug cromolynNature, 1980
- Antiallergic Drug Cromolyn May Inhibit Histamine Secretion by Regulating Phosphorylation of a Mast Cell ProteinScience, 1980
- Antigen-induced neutrophil chemotactic activity in man *1Correlation with bronchospasm and inhibition by disodium cromoglycateJournal of Allergy and Clinical Immunology, 1978
- Disodium Cromoglycate (FPL 670) (‘Intal’*): a Specific Inhibitor of Reaginic Antibody–Antigen MechanismsNature, 1967